Mn gene and protein
CA 2763066 A1 · Owner: Institute Of Virology · Inventors: Pastorekova, Silvia; Zavada, Jan; Pastorek, Jaromir
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Identified herein is the location of the MN protein binding site and MN , proteins/polypeptides , that compete for attachment to vertebrate cells with immobilized MN protein. Such MN , proteins/polypeptides prevent cell-cell adhesion and the formation of intercellular contacts. , The MN protein binding site is a therapeutic target that can be blocked by organic or , inorganic molecules, preferably organic molecules more preferably , proteins/polypeptides that specifically bind to that site. Therapeutic methods for inhibiting the growth of , preneoplastic/neoplastic vertebrate cells that abnormally express MN protein are disclosed. , Vectors are provided that encode the variable …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 22, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.